ABSTRACT
UNLABELLED: What are the specific parameters of dental health that present with modifications in osteoporosis (OP)? Both OP and a decreased bone mass can affect dental health. A low mineral density may lead to the loss of dentures because the jaw is exposed to the effects of periodontitis and without strong sustainability the teeth may lose their stability. INTRODUCTION: We compared the values of the periodontal index (IP) with a T score for women presenting with OP at menopause and those without OP. We found that there is a relation between OP and the loss of bone mass at the oral-facial level. METHODS: The study included 87 patients, aged between 35 and 75 years. We correlated gums and IP with the T score for the two groups. RESULTS: We found a significant difference between the values of the IP index for the group with OP in comparison with the control group. Thus a correlation between OP and IP was confirmed. CONCLUSIONS: IP was statistically significantly higher in women at menopause with OP than those without OP. Gum retraction was significantly higher in women at menopause with OP than in the control group. There was thus a real correlation between bone mineral density (BMD) and IP, while between BMD and dental mobility we found no correlation.
Subject(s)
Osteoporosis/complications , Stomatognathic Diseases/etiology , Adult , Aged , Bone Density/physiology , Case-Control Studies , Female , Gingival Recession/etiology , Gingival Recession/physiopathology , Humans , Menopause/physiology , Middle Aged , Osteoporosis/physiopathology , Osteoporosis, Postmenopausal/complications , Osteoporosis, Postmenopausal/physiopathology , Periodontal Index , Stomatognathic Diseases/physiopathologyABSTRACT
Introduction. Cardiovascular disease (CVD) is the major cause of premature death worldwide. Hundreds of risk factors have been associated with cardiovascular disease. Recent extensive evidence supports inflammation as a key pathogenetic mechanism in the development and progression of atherosclerosis and in triggering clinical atherothrombotic CVD events. C-reactive protein (CRP) is one possible marker of vascular inflammation and plays a direct role in promoting vascular inflammation, vessel damage and clinical CVD events. Material and method. The purpose of this study was to evaluate the correlation between CRP level and the global cardiovascular risk. We evaluated 100 patients with cardiovascular risk factors, using the systematic coronary risk evalution (SCORE) charts for high risk regions of Europe and we determined the CRP level, using the nephelometric method. Results. By their SCORE chart, 44% of the patients are in the moderate risk category, and almost 40% in the high risk category, the rest of them (16%) are in the low and very high risk category. A statistically significant p value (p<0.05) was observed between patients with CRP<10mg/L, who had a lower sistolic blood pressure than patients with CRP≥10mg/L, Conclusion. The CRP level over 10mg/L is correlated with an over 4% risk of developing a fatal CVD in 10 years. The acute phase reactant, CRP, a simple downstream marker of inflammation, has now emerged as a major cardiovascular risk factor.
